The global lysosomal storage disease treatment market size was estimated at USD 4.54 billion in 2024 and is projected to reach USD 6.68 billion by 2033, growing at a CAGR of 4.54% from 2025 to 2033. This steady growth trajectory is primarily driven by multiple factors, including the enhancement of diagnostic capabilities, significant advancements in enzyme replacement therapies and...